Precigen Inc (PGEN)

3.86 -0.19  -4.69% NASDAQ Nov 26, 16:00 USD

Precigen Total Liabilities (Quarterly):

245.65M for Sept. 30, 2021
View 4,000+ financial data types
Browse...
View Full Chart

Total Liabilities (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Total Liabilities (Quarterly) Data

View and export this data going back to 2012. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 245.65M
June 30, 2021 243.38M
March 31, 2021 232.19M
Dec. 31, 2020 247.41M
Sept. 30, 2020 277.63M
June 30, 2020 312.17M
March 31, 2020 317.44M
Dec. 31, 2019 384.05M
Sept. 30, 2019 376.48M
June 30, 2019 375.96M
March 31, 2019 375.04M
Dec. 31, 2018 337.46M
Sept. 30, 2018 424.97M
June 30, 2018 258.01M
March 31, 2018 324.24M
Dec. 31, 2017 300.31M
Sept. 30, 2017 345.08M
June 30, 2017 362.44M
   
March 31, 2017 365.77M
Dec. 31, 2016 379.82M
Sept. 30, 2016 397.17M
June 30, 2016 402.93M
March 31, 2016 287.60M
Dec. 31, 2015 277.16M
Sept. 30, 2015 260.26M
June 30, 2015 306.01M
March 31, 2015 166.64M
Dec. 31, 2014 166.98M
Sept. 30, 2014 158.66M
June 30, 2014 112.17M
March 31, 2014 115.91M
Dec. 31, 2013 88.13M
Sept. 30, 2013 82.99M
June 30, 2013 644.98M
March 31, 2013 71.94M
Dec. 31, 2012 473.20M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Benchmarks

Danaher Corp 39.04B
Regenxbio Inc 338.98M
Allogene Therapeutics Inc 109.30M

Total Liabilities (Quarterly) Range, Past 5 Years

Minimum 232.19M Mar 2021
Maximum 424.97M Sep 2018
Average 324.28M

Total Liabilities (Quarterly) Related Metrics

Total Assets (Quarterly) 376.90M
Shareholders Equity (Quarterly) 131.25M
Debt to Equity Ratio 1.373
Current Ratio 5.281
Net Debt Paydown Yield 0.84%

News

Precigen gains 9% as Director buy 1M shares
SA Breaking News 11/24 14:55 ET
Insider Buy: Precigen
MT Newswires 11/24 06:00 ET
Precigen Appoints CFO
MT Newswires 10/12 10:16 ET
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.